Annals of the New York Academy of Sciences, The Future of Hormone Therapy: What Basic Science and Clinical Studies Teach Us / Edition 1

Paperback (Print)
Buy New
Buy New from BN.com
$159.95
Used and New from Other Sellers
Used and New from Other Sellers
from $2.48
Usually ships in 1-2 business days
(Save 98%)
Other sellers (Paperback)
  • All (12) from $2.48   
  • New (5) from $122.56   
  • Used (7) from $2.48   

Overview

This volume brings together contributions from basic scientists, epidemiologists, and practicing clinicians whose expertise or clinical practice involves the study or administration of gonadal hormones. Our current knowledge of the biology of gonadal hormones is assessed, and the question is explored of the gaps in knowledge that need to be addressed through additional research.

Other questions explored include the following: What is the appropriate population to study? What is the therapeutic window for hormone therapy and/or estrogen therapy? What are the appropriate formulations of HT and ET? What should be considered the most appropriate design for clinical trials that address the efficacy of HT/ET? What are appropriate surrogate markers of neurological decline/impairment? What are the best in vitro and in vivo models to address the efficacy of postmenopausal HT or ET?

NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.

ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.

Read More Show Less

Product Details

Table of Contents

Introduction. (Meharvan Singh and James W. Simpkins).

Part I: What Is the Appropriate Population of Women to Study/Treat When Considering Hormone/Estrogen Therapy?.

1. Surgical Menopause, Estrogen, and Cognitive Function in Women: What Do the Findings Tell Us? (Barbara B. Sherwin).

2. Menopausal Hot Flashes and Development of Cognitive Impairment. (Anna Ratka).

3. Depression, the Perimenopause, and Estrogen Therapy. (Peter J. Schmidt).

Part II: What Is the Ideal Therapeutic Window for Hormone/Estrogen Therapy?.

4. Is the Estrogen Controversy Over? Deconstructing the Women's Health Initiative Study: A Critical Evaluation of the Evidence. (S Mitchell Harman, Frederick Naftolin, Eliot A. Brinton, and Debra R. Judelson).

5. Investigative Models for Determining Hormone Therapy-Induced Outcomes in Brain: Evidence in Support of a Healthy Cell Bias of Estrogen Action. (Roberta Diaz Brinton).

6. Estrogen: A Neuroprotective or Proinflammatory Hormone? Emerging Evidence from Reproductive Aging Models. (Farida Sohrabji).

Part III: What Are Appropriate Formulations of Hormone/Estrogen Therapy?.

7. Clinical Pharmacology and Differential Cognitive Efficacy of Estrogen Preparations. (Carey E. Gleason, Cynthia M. Carlsson, Sterling Johnson, Craig Atwood, and Sanjay Asthana).

8. Development of 17-Estradiol as a Neuroprotective Therapeutic Agent: Rationale and Results from a Phase I Clinical Study. (James A. Dykens, Walter H. Moos, and Neil Howell).

9. Estrogen and the Brain: Beyond ER-, ER-ß, and 17ß-Estradiol. (C Dominique Toran-Allerand).

10. Mechanisms of Progesterone-Induced Neuroprotection. (Meharvan Singh).

11. The Case for Progesterone. (Donald G. Stein).

Part IV: What Is the Most Appropriate Design for Clinical Trials That Address the Efficacy of Hormone/Estrogen Therapy?.

12. Methodological Issues in Estrogen Treatment Trials for Alzheimer's Disease. (Ruth A. Mulnard).

13. A Systematic Review of Clinical Trials of Hormone Therapy on Cognitive Function: Effects of Age at Initiation and Progestin Use. (Pauline M. Maki).

Part V: What Are Appropriate Surrogate Markers of Neurological Decline and What Experimental Models Are Best to Assess the Efficacy of Hormone/Estrogen Therapy?.

14. Estrogen Bows to a New Master: The Role of Gonadotropins in Alzheimer Pathogenesis. (Kate M. Webber, Gemma Casadesus, Michael W. Marlatt, George Perry, Clive R. Hamlin, Craig S. Atwood, Richard L. Bowen, and Mark A. Smith).

15. Estradiol Prevents Neural Tau Hyperphosphorylation Characteristic of Alzheimer's Disease. (Margarita Alvarez-De-La-Rosa, Ivaldo Silva, Jon Nilsen, M M Pérez, Luis Miguel García-Segura, Jesús Ávila, and Frederick Naftolin).

16. Estrogens and Cerebrovascular Stroke: What Do Animal Models Teach Us? (Phyllis M. Wise).

17. Role of Nonfeminizing Estrogens in Brain Protection from Cerebral Ischemia: An Animal Model of Alzheimer's Disease Neuropathology. (James W. Simpkins, Yi Wen, Evelyn Perez, Shaohua Yang, and Xiaofei Wang).

18. Impact of Metabolism on the Safety of Estrogen Therapy. ( Katalin Prokai-Tatrai and Laszlo Prokai).

19. Summary. (Meharvan Singh and James W. Simpkins).

Index. of Contributors.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)